Berberine Shows Promise for Pancreatic Cell Recovery in Type 1 Diabetes Research

A new study in diabetic rats found that berberine, a compound from a traditional medicinal plant, reduced blood sugar and showed signs of restoring damaged pancreatic cells. These early findings suggest a potential avenue for research, though human studies are still needed.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cure researchbeta cellsimmunotherapyadvancements

Key takeaways

Berberine reduced fasting blood sugar by about 50% in diabetic rats when given orally for 60 days
The treatment increased GABA levels and gastrin levels, markers that may support pancreatic cell function
Pancreatic tissue showed less damage and shrinkage after berberine treatment compared to untreated diabetic rats
This is early-stage animal research; human clinical trials are required before any conclusions about effectiveness in people can be drawn

What Is Berberine?

Berberine is a compound found in Berberis vulgaris, a plant long used in traditional Iranian medicine. The plant has been studied for its potential glucose-lowering, antioxidant, and anti-inflammatory properties. This new research examined whether berberine might help regenerate beta cells—the insulin-producing cells damaged in Type 1 diabetes.

How the Study Was Conducted

Researchers induced diabetes in rats using streptozotocin and then treated two groups with daily oral doses of berberine (50 and 100 mg/kg body weight) for 60 days. They measured blood sugar, insulin levels, pancreatic cell markers, and examined pancreatic tissue under a microscope to assess damage and healing.

What the Results Showed

Berberine treatment significantly reduced fasting blood sugar—dropping from 616 mg/dl in untreated diabetic rats to 327–296 mg/dl in treated groups. The compound also increased GABA levels nearly 7-fold and raised gastrin levels, both markers associated with pancreatic cell function.

When researchers examined pancreatic tissue, they found reduced shrinkage and damage in the islets—the clusters of beta cells—compared to untreated diabetic rats. Expression of Pdx1, a gene important for beta cell development, also increased in the berberine-treated groups.

What This Means (and Doesn't Mean)

These findings are encouraging for further research into berberine's mechanisms in Type 1 diabetes. However, this is early-stage animal research. Results in rats do not automatically translate to humans, and many promising laboratory findings do not lead to effective treatments.

Much more work—including safety studies and clinical trials in people—would be needed before berberine could be considered a treatment option. Anyone interested in Type 1 diabetes research should continue following studies from reputable institutions and speaking with their healthcare team about evidence-based treatment options.

Evidence label

Source: Iranian journal of basic medical sciences. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.